Zoetis
ZTS • NYSE
Zoetis is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Kristin C. Peck, with a market cap of $47.8B.
CEOKristin C. Peck
Next Earnings
Upcoming earnings announcement for Zoetis
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.62
Revenue Estimate
$2.3B
Earnings History
Past 12 earnings reports for Zoetis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Q4 2025 | $1.48Est: $1.40 | +5.7% | $2.4BEst: $2.4B | +0.9% |  10-K |
| Nov 4, 2025 | Q3 2025 | $1.70Est: $1.62 | +4.9% | $2.4BEst: $2.4B | -0.3% | 10-Q |
| Aug 5, 2025 | Q2 2025 | $1.76Est: $1.62 | +8.6% | $2.5BEst: $2.4B | +4.0% | 10-Q |
| May 6, 2025 | Q1 2025 | $1.48Est: $1.40 | +5.7% | $2.2BEst: $2.2B | +1.4% | 10-Q |
| Feb 13, 2025 | Q4 2024 | $1.40Est: $1.34 | +4.5% | $2.3BEst: $2.3B | +0.7% | 10-K |
| Nov 4, 2024 | Q3 2024 | $1.58Est: $1.45 | +9.0% | $2.4BEst: $2.3B | +4.3% | 10-Q |
| Aug 6, 2024 | Q2 2024 | $1.56Est: $1.50 | +4.0% | $2.4BEst: $2.3B | +2.2% | 10-Q |
| May 2, 2024 | Q1 2024 | $1.38Est: $1.34 | +3.0% | $2.2BEst: $2.1B | +2.8% | 10-Q |
| Feb 13, 2024 | Q4 2023 | $1.24Est: $1.32 | -6.1% | $2.2BEst: $2.2B | +1.1% | 10-K |
| Nov 2, 2023 | Q3 2023 | $1.36Est: $1.36 | 0.0% | $2.2BEst: $2.2B | -1.4% | — |
| Aug 8, 2023 | Q2 2023 | $1.41Est: $1.32 | +6.8% | $2.2BEst: $2.2B | +0.5% | 10-Q |
| May 4, 2023 | Q1 2023 | $1.31Est: $1.26 | +4.0% | $2.0BEst: $2.0B | -0.5% | — |